Platform
Features
0 followers
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Niels C. Riedemann
7 members
5 members
4 members
3 members
Synthekine
3 followers
PMV Pharmaceuticals
1 follower
BIOTRONIK
5 followers
KWS Group
GALY
Thermo Fisher Scientific
144 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
DARI Motion, Inc.
2 followers
Agilent Technologies
61 followers
Discover companies